Passero VA, Branstetter BF, Shuai Y, Heron DE, Gibson MK, Lai SY, et al. Response assessment by combined PET-CT scan versus CT scan alone using RECIST in patients with locally advanced head and neck cancer treated with chemoradiotherapy. Ann Oncol. 2010 Nov; 21 (11):2278–2283....
更重要的是,医生可以根据患者的个体差异设定任意扫描范围,有效避免了传统PET/CT因床位限制而扫描的额外FOV,大幅度降低了扫描的时间。 参考文献 1. Kao YH, Tan EH, Teo TK, Ng CE, Goh SW: Imaging discordance between hepatic angiograp...
Kornberg等的研究也发现接受肝移植治疗的HCC患者中,PET/CT阴性患者与阳性患者的5年无病生存率分别为93.3%和38.1%,PET/CT阳性组复发率为58.5%,而PET/CT阴性患者复发率仅为6.7%[42]。对移植前进行18F-FDG PET/CT显像的肝移植患者数据进行分析发现,PET...
Triage of Limited Versus Extensive Disease on F-FDG PET/CT Scan in Small Cell lung Cancer 来自 EBSCO 喜欢 0 阅读量: 12 作者:R Saima,H Bashir,NI Khalid 摘要: Objectives:Small cell lung cancer (SCLC) is an aggressive neuroendocrine carcinoma, which accounts for 10-15% of pulmonary cancers ...
Response assessment by combined PET–CT scan versus CT scan alone using RECIST in patients with locally advanced head and neck cancer treated with chemorad... Purpose: RECIST have limitations when applied to potentially curable locally advanced squamous cell carcinoma of the head and neck (SCCHN)....
正电子发射断层扫描/计算机断层扫描(PET/CT)提供的代谢信息有助于肿瘤筛查初始分期、治疗计划、反应评估,并在较小程度上可用于肿瘤的随访;PET/CT成像在放射治疗中的渐进式整合在肿瘤间和肿瘤内恶性病变的生物异质性中具有其基本原理,需要单独调整辐射剂量以获得癌症患者的有效局部肿瘤控制;PET/CT提供有关肿瘤病变的...
纳入16名需要进行手术的FCD II患者,收集这些患者的临床资料,包括临床表现,各种电生理学及影像学数据等,患者接受18F-SynVesT-1 PET/CT扫描和18F-FDG PET/CT扫描,同时招募16名健康志愿者进行18F-SynVesT-1 PET/CT扫描以作为健康对照组,使用视觉评估和半定量分析(包括不对称指数:AI,标准摄取比值:SUVr),结合患者术...
Before start of SABR, all patients underwent a CT-scan of the tumour and surrounding tissues, and in patients with bone metastasis a Magnetic Resonance Imaging (MRI)-scan was also performed, for target definition of the detected lesions. A vacuum matrass was used for immobilization purposes duri...
(median: 5 mm). After fasting for a minimum of 6 h and undergoing confirmation of a blood glucose level less than 200 mg/dL, patients received an intravenous infusion of 259–740 MBq 18F-FDG. A CT scan was performed for anatomic correlation and attenuation correction; PET images ...
Non–Small Cell Lung Cancer Staging: Efficacy Comparison of Integrated PET/CT versus 3.0-T Whole-Body MR Imaging1 Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0 T whole-body MRI. Radiology. 2008;248(2):632–42.Yi CA, ... CA Yi,KM Shin,KS Lee...